Literature DB >> 3661615

Reversible acute decrease in renal function by NSAIDs in cirrhosis.

D C Brater1, S A Anderson, D Brown-Cartwright.   

Abstract

The effects of sulindac were compared with those of ibuprofen or naproxen on creatinine clearance and urinary prostanoids in patients with severe alcoholic cirrhosis. Sulindac caused acute declines in all renal parameters in four of five patients. The effect occurred with serum concentrations of the active sulfide metabolite comparable to those in patients with no hepatic impairment. The patient who was not affected had less effects on urinary PGE2 and TxB2 and no effect on 6-keto PGF1 alpha. In this patient, dosing with ibuprofen caused pronounced declines in all urinary prostanoids and a decrease in creatinine clearance. Two other patients treated with ibuprofen and one treated with naproxen also suffered decrements in all parameters. In conclusion, sulindac had suppressant effects on renal prostanoids associated with declines in creatinine clearance in these patients with cirrhosis, indicating a need for similar cautions with its use as with other NSAIDs.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3661615     DOI: 10.1097/00000441-198709000-00007

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  9 in total

1.  Acute renal dysfunction in patients with alcoholic hepatitis.

Authors:  Robin Arora; Shweta Kathuria; Nishant Jalandhara
Journal:  World J Hepatol       Date:  2011-05-27

2.  Liver cirrhosis induces renal and liver phospholipase A2 activity in rats.

Authors:  B S Vishwanath; F J Frey; G Escher; J Reichen; B M Frey
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

3.  Use of over-the-counter analgesics is not associated with acute decompensation in patients with cirrhosis.

Authors:  Sakib K Khalid; Jill Lane; Victor Navarro; Guadalupe Garcia-Tsao
Journal:  Clin Gastroenterol Hepatol       Date:  2009-04-24       Impact factor: 11.382

4.  Analgesics in patients with hepatic impairment: pharmacology and clinical implications.

Authors:  Marija Bosilkovska; Bernhard Walder; Marie Besson; Youssef Daali; Jules Desmeules
Journal:  Drugs       Date:  2012-08-20       Impact factor: 9.546

5.  Use of over-the-counter analgesics in patients with chronic liver disease: physicians' recommendations.

Authors:  Simona Rossi; David N Assis; Monica Awsare; Mark Brunner; Kevin Skole; Jitha Rai; Jocelyn Andrel; Steven K Herrine; Rajender K Reddy; Victor J Navarro
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 6.  The therapeutic use of analgesics in patients with liver cirrhosis: a literature review and evidence-based recommendations.

Authors:  Farnad Imani; Mahsa Motavaf; Saeid Safari; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2014-10-11       Impact factor: 0.660

7.  The Prescription Pattern of Acetaminophen and Non-Steroidal Anti-Inflammatory Drugs in Patients with Liver Cirrhosis.

Authors:  Young Mi Hong; Ki Tae Yoon; Jeong Heo; Hyun Young Woo; Won Lim; Dae Seong An; Jun Hee Han; Mong Cho
Journal:  J Korean Med Sci       Date:  2016-10       Impact factor: 2.153

8.  Monocyte dysfunction in decompensated cirrhosis is mediated by the prostaglandin E2-EP4 pathway.

Authors:  Alexander A Maini; Natalia Becares; Louise China; Thais H Tittanegro; Amit Patel; Roel P H De Maeyer; Nekisa Zakeri; Tu Vinh Long; Lucy Ly; Derek W Gilroy; Alastair O'Brien
Journal:  JHEP Rep       Date:  2021-08-04

Review 9.  Nonsteroidal Anti-Inflammatory Drugs and the Kidney.

Authors:  Walter H Hörl
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.